CAS 1438416-21-7

2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate

Description:

2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate, identified by its CAS number 1438416-21-7, is a synthetic organic compound characterized by its complex molecular structure, which includes a pyrrolidine ring and a piperazine moiety. This compound typically exhibits properties associated with both heterocyclic and aromatic systems, contributing to its potential biological activity. The presence of the dioxopyrrolidine and piperazine functionalities suggests that it may engage in hydrogen bonding and other intermolecular interactions, which can influence its solubility and reactivity. The chlorinated phenyl groups may enhance lipophilicity, potentially affecting its pharmacokinetic properties. Such compounds are often investigated for their potential therapeutic applications, particularly in the fields of medicinal chemistry and drug development. However, specific characteristics such as melting point, boiling point, and solubility would require empirical data for precise determination. Overall, this compound represents a class of molecules that may exhibit interesting biological activities due to their structural features.

Formula: C₂₂H₂₁Cl₂N₃O₄

InChI: InChI=1S/C22H21Cl2N3O4/c23-17-5-1-15(2-6-17)21(16-3-7-18(24)8-4-16)25-11-13-26(14-12-25)22(30)31-27-19(28)9-10-20(27)29/h1-8,21H,9-14H2

InChI key: InChIKey=BEADRWVIFHOSGN-UHFFFAOYSA-N

SMILES: C(N1CCN(C(ON2C(=O)CCC2=O)=O)CC1)(C3=CC=C(Cl)C=C3)C4=CC=C(Cl)C=C4

Synonyms:

• 1-Piperazinecarboxylic acid, 4-[bis(4-chlorophenyl)methyl]-, 2,5-dioxo-1-pyrrolidinyl ester
• 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate
• MJN 110

2,5-Dioxopyrrolidin-1-Yl 4-(Bis(4-Chlorophenyl)Methyl)Piperazine-1-Carboxylate

CAS: 1438416-21-7

2,5-Dioxopyrrolidin-1-Yl 4-(Bis(4-Chlorophenyl)Methyl)Piperazine-1-Carboxylate

Purity: 98%

Molecular weight: 462.33g/mol

Ref: 54-OR1022899

MJN110

CAS: 1438416-21-7

MJN110

Purity: ≥98%

Molecular weight: 462.33g/mol

Ref: 54-BUP06196

MJN110

CAS: 1438416-21-7

MJN110 (Cravatt Reagent) is a potent and selective MAGL inhibitor. MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.

Formula: C₂₂H₂₁Cl₂N₃O₄

Purity: 99.406%

Color and Shape: Solid

Molecular weight: 462.33

Ref: TM-T5815

2,5-DIOXOPYRROLIDIN-1-YL 4-(BIS(4-CHLOROPHENYL)METHYL)PIPERAZINE-1-CARBOXYLATE

CAS: 1438416-21-7

Purity: 98%

Molecular weight: 462.3299866

Ref: 10-F840878

MJN110

CAS: 1438416-21-7

MJN110 is a novel drug that inhibits the activity of fatty acid amide hydrolase (FAAH), an enzyme that breaks down anandamide, one of the body's natural endocannabinoids. MJN110 has been shown to have potent antinociceptive and anti-inflammatory effects in animal models. It also has been shown to have beneficial effects on chronic viral hepatitis, as well as other diseases such as type 2 diabetes, neuropathic pain, and Parkinson's disease. MJN110 may be used as an analgesic, anti-inflammatory agent, or agent for treating chronic viral hepatitis.

Formula: C₂₂H₂₁Cl₂N₃O₄

Purity: Min. 95%

Molecular weight: 462.33 g/mol

Ref: 3D-NHC41621